🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 5 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 22,78 24,02 22,73 23,53 +2,48% 5,66% 1.171.400
03/03/2025 24,04 24,14 22,77 22,96 -4,53% 5,70% 1.238.800
28/02/2025 26,00 26,34 22,87 24,05 -5,24% 13,35% 1.671.000
27/02/2025 25,34 26,10 25,31 25,38 -0,39% 3,12% 761.600
26/02/2025 25,13 26,69 24,98 25,48 +1,51% 6,80% 1.609.400
25/02/2025 25,14 25,58 24,74 25,10 -0,59% 3,34% 892.200
24/02/2025 25,16 25,54 24,93 25,25 +0,36% 2,42% 519.200
21/02/2025 26,02 26,17 25,09 25,16 -2,25% 4,15% 593.900
20/02/2025 25,87 26,28 25,69 25,74 -1,15% 2,28% 502.700
19/02/2025 26,37 26,89 25,94 26,04 -1,51% 3,60% 846.300
18/02/2025 25,53 26,50 25,41 26,44 +3,93% 4,27% 759.700
14/02/2025 26,57 27,00 25,44 25,44 -4,11% 5,87% 615.900
13/02/2025 27,27 27,27 26,16 26,53 -2,21% 4,07% 476.400
12/02/2025 27,24 27,30 26,28 27,13 -0,44% 3,74% 457.900
11/02/2025 26,17 27,36 25,78 27,25 +4,41% 6,04% 774.100
10/02/2025 26,56 26,56 25,77 26,10 +0,00% 2,97% 672.300
07/02/2025 26,41 26,51 25,37 26,10 -0,61% 4,32% 562.800
06/02/2025 27,17 27,17 26,18 26,26 -3,06% 3,64% 913.700
05/02/2025 26,58 27,11 25,93 27,09 +1,88% 4,44% 908.700
04/02/2025 25,63 26,86 25,46 26,59 +3,26% 5,46% 747.500
03/02/2025 25,65 27,10 25,06 25,75 -2,20% 7,95% 814.200
31/01/2025 26,20 26,50 25,74 26,33 +0,34% 2,90% 849.300
30/01/2025 27,00 27,59 25,67 26,24 +0,81% 7,11% 1.000.500
29/01/2025 25,70 26,76 25,39 26,03 +1,09% 5,33% 980.300
28/01/2025 25,79 26,93 24,92 25,75 +0,35% 7,79% 1.138.600
27/01/2025 24,88 25,77 24,41 25,66 +4,65% 5,47% 921.100
24/01/2025 23,36 25,29 23,20 24,52 +5,10% 8,95% 1.584.900
23/01/2025 22,47 23,51 22,26 23,33 +3,92% 5,56% 1.267.000
22/01/2025 22,84 23,00 22,13 22,45 -1,71% 3,81% 477.900
21/01/2025 22,23 22,88 21,84 22,84 +2,15% 4,68% 819.500